Delivery Order W81K0220D0003-W81K0223F0109
Award Date
10/1/23
Potential Completion Date
9/30/24
Potential Value
$13K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Inseonmedics Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract worth $121,790.00 to Inseonmedics Inc., a for-profit corporation that specializes in providing specialized medical reagents for diagnostic and laboratory purposes. The contract, which has a period of performance from October 1, 2024 to September 30, 2029, is for the procurement of VENTANA HE600 reagents to support the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical...
Inseonmedics Inc. was awarded a $20,305 firm-fixed price delivery order against its single-award indefinite delivery contract with the Defense Health Agency to supply VENTANA HE600 reagents for use at the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical Platform in South Korea. The contract, valued at up to $649,470, provides VENTANA HE600 reagents compatible with immunohistochemistry staining platforms to support medical and biological defense...
This is a federal contract award from the Defense Health Agency (DHA) to Inseonmedics Inc., a for-profit corporation registered in SAM.gov. The contract, identified as W81K0220D0003|W81K0224F0054, is for the delivery of VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms to support military healthcare and biological defense programs at U.S. military medical facilities in South Korea. The contract is a delivery order under an Indefinite...
The Department of the Army Medical Command awarded a $32,650 firm fixed-price delivery order to Inseonmedics Inc. of South Korea under a blanket purchase agreement for reagents to support the VENTANA HE600 immunohistochemistry staining platform. The reagents will support the U.S. military's laboratory in BDAACH, Korea and must be delivered by September 30, 2020. No set-aside provision was applied to this order to fulfill testing requirements at the Army medical facility in the Republic of...
Inseonmedics Inc. has been awarded a $30,850 firm fixed price delivery order for VENTANA HE600 reagents to support the Department of the Army Medical Command's biological defense analytical and archiving capabilities in South Korea. The delivery order exercises the third option year under the Army's indefinite-delivery/indefinite-quantity contract vehicle for laboratory equipment and supplies. No set-aside provisions were applied to this award. The reagents will support continued biological...
This is a firm fixed price delivery order contract awarded by the U.S. Department of the Army Medical Command (MEDCOM) to Synyoung Biomedics, a South Korean for-profit company. The contract has a ceiling value of $88,417.00 and is for the delivery of reagents for arterial blood gas analyzers to support the Brian D. Allgood Army Community Hospital in South Korea. This delivery order was issued against a larger, single award indefinite delivery contract with a potential value of $421,130.00 that...
This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to SL Meditech CO., a for-profit company, for the provision of hematology reagents and analyzers. The contract has a ceiling value of $258,020.00 and a performance period from November 2023 through September 2028, with the option to extend. The original solicitation, W81K0223Q0111, was a combined synopsis/solicitation for commercial items to provide hematology reagents and analyzers to support medical...
The U.S. Department of Defense's Defense Health Agency awarded a $1,168,449.00 firm-fixed-price purchase order contract to SL Meditech CO., a for-profit vendor, to provide hematology reagents and analyzers to the Brian D. Allgood Army Community Hospital and four other medical clinics in South Korea. The contract has a base period from August 2023 through September 2024, with four one-year option periods extending performance up to September 2027. This requirement was originally solicited through...
The U.S. Defense Health Agency (DHA) awarded a firm fixed price delivery order contract to Synyoung Biomedics, a for-profit company located in South Korea. The contract, valued at $65,507.00, is for the provision of blood gas analyzers and associated reagents to support medical facilities in South Korea that serve U.S. military personnel. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract awarded to Synyoung Biomedics in October 2022, which has a potential value...
This firm-fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to SL Meditech CO., a for-profit sole proprietorship, for the supply of hematology reagents and an analyzer to support the medical readiness and testing needs of U.S. military forces stationed in South Korea. The contract, valued at $252,870.00, has an initial base period from September 2023 through September 2024, with four 12-month option periods extending performance through September 2027. The...